Juvenescence
Phase 1We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
Founded
2016
Focus
BiologicsSmall Molecules
About
We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
Funding History
3Total raised: $308M
Series C$162MMike Cannon-BrookesMar 15, 2021
Series B$100MMike Cannon-BrookesDec 15, 2019
Series A$46MGrok VenturesMay 15, 2018
Company Info
TypePrivate
Founded2016
LocationLondon, United Kingdom
StagePhase 1
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile